Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients

By Sagara Yasuaki  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 212-217

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life in Postmenopausal Patients with Breast Cancer after Failure of Tamoxifen: Formestane Versus Megestrol Acetate as Second-line Hormonal Treatment

By Bernhard J.   Castiglione-Gertsch M.   Schmitz S.-F.H.   Thurlimann B.   Cavalli F.   Morant R.   Fey M.F.   Bonnefoi H.   Goldhirsch A.   Hurny C.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 913-920

Elsevier

Access to resources Recommend Favorite

A Patient with Axillary Node Metastasis from Breast Cancer Who Responded to Trastuzumab/Capecitabine Combination Therapy

By Tokugawa Tomoki   Kobayashi Aya   Matsuyama Tomohiko   Imai Shunsuke   Koyama Hiroshi  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 467-469

Sunmedia

Access to resources Recommend Favorite

Formestane Versus Megestrol Acetate in Postmenopausal Breast Cancer Patients After Failure of Tamoxifen: a Phase III Prospective Randomised Cross Over Trial of Second-line Hormonal Treatment (SAKK 2090)

By Swiss Group for Clinical Cancer Research SAKK   Thurlimann B.   Castiglione M.   Hsu-Schmitz S.F.   Cavalli F.   Bonnefoi H.   Fey M.F.   Morant R.   Lohnert T.   Goldhirsch A.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1017-1024

Elsevier

Access to resources Recommend Favorite

Homoharringtonine is an effective therapy for patients with polycythemia vera or essential thrombocythemia who have failed or were intolerant to hydroxycarbamide or interferon-α therapy

By Li Yufeng   Zhu Jiabin   Ding Banghe  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 922-926

Springer Publishing Company

Access to resources Recommend Favorite